RUC’s Active Projects
- MORPH: Monitoring Drug Efficacy through Multi-Omics Research Initiative in Alzheimer’s Disease (MEMORI-AD)
- MORPH: Determinants of acquisition, persistence, and clearance of oncogenic cervical human papillomavirus infection in a cohort of women in rural and urban Philippines using a multi-OMICS approach (DEFEAT HPV)
- MORPH: Molecular Epidemiology of Mycobacterium tuberculosis and Human Immunodeficiency Virus and Immunophenotyping of Adult Filipino TB/HIV Co-infected Patients (TB-HIV)
- MORPH: Identification of Biomarkers to Distinguish Between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma (Thyroid carcinoma)
- Clinical and Laboratory Profile, Management and Outcome of Pediatric SARS CoV-2 Infection Admitted in Selected Public and Private Hospitals in the Philippines: A Multicenter Study (PIDSP)
- Vaccine Immune Response and Outcome Monitoring with Epitope Sequences (VIROMES): Application to WHO SOLIDARITY COVID-19 Vaccine Trial
- Outcomes of Patients with Moderate to Severe SARS-CoV-2 Infection and Abnormal Coagulation Parameters in a Philippine Tertiary
- Philippines HIV Observational Database
RUC’s Completed Projects
- Genetics, Immunological and Neurological Long-Term Consequences in prospective Covid-19 Cohort in Thailand, Japan, Philippines and USA (GINCO Cohort e-ASIA)
- Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients with Covid-19
- Utility of Various Biomarkers in Detecting Cytokine Storm Syndromes and Predicting In-Hospital Mortality Among Patients with Confirmed SARS-CoV-2 at a Philippine Tertiary Hospital
- Public Health Emergency SOLIDARITY TRIAL: An International Randomised Trial of Additional Treatments for Covid-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care
- Collection and Archiving of Patient Sera and Plasma for Immunochemical Analysis to Detect Antibodies Against Infectious Pathogens
- Intravenous Tocilizumab in the Treatment of Patients with Severe and Critical COVID-19-related Pneumonia
- Virgin Coconut Oil as Adjunctive Therapy for Hospitalized COVID-19 Patients